Postprandial Endothelial Dysfunction After a High-Fat Meal in HIV-infected Men (PERTH)
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to examine the postprandial (anytime after a meal) effect of different dietary fats on endothelial function in HIV-infected and HIV-uninfected men.
| Condition | Intervention |
|---|---|
|
HIV Infection Cardiovascular Risk HIV Infections |
Other: Omega-3 study meal Other: Saturated fat study meal |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Cross-Sectional |
| Official Title: | Postprandial Endothelial Dysfunction After a High-Fat Meal in HIV-infected Men |
- To measure flow-mediated dilation before and after eating the two study meals. [ Time Frame: Study visit 1 and 2 ] [ Designated as safety issue: No ]
- To compare the effect of different dietary fats on endothelial function. [ Time Frame: Study visit 1 and 2 ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 50 |
| Study Start Date: | January 2008 |
| Estimated Study Completion Date: | January 2010 |
| Estimated Primary Completion Date: | January 2010 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
1
High omega-3
|
Other: Omega-3 study meal
Participant will eat a study meal high in omega-3 fatty acids.
|
|
2
High saturated fat
|
Other: Saturated fat study meal
Participant will eat a study meal high in saturated fat.
|
Detailed Description:
This study requires two visits. Once determined eligible by the study criteria, during the first visit the participant will be randomly placed to receive one of two high-fat meals. The participant will receive the other study meal during the second visit. At each visit, brachial artery ultrasounds will be performed before and 3 hours after the meal is eaten. The sample size is 50 subjects. This study will be conducted at the Clinical Research Center at Tufts Medical Center.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
HIV-infected white males who have identified themselves with concerns about diet or cardiovascular disease.
Inclusion Criteria:
- HIV-positive white male aged >18 years
Under one of the following treatment categories:
- Treatment naive or have never taken any HIV medications
- Taking Kaletra
- Taking Sustiva
- Taking Atripla
Exclusion Criteria:
- Smoker
Pre-existing diagnosis or treatment for the following:
- Lipid disorder
- Cardiovascular disease
- High blood pressure
- Diabetes
- Acute opportunistic infection or malignancy within last 3 months or current therapy for either
- Active IV drug use
Contacts and Locations| Contact: Mari Imai | 617-636-3496 | cindy.imai@tufts.edu |
| United States, Massachusetts | |
| Tufts University | Recruiting |
| Boston, Massachusetts, United States, 02111 | |
| Principal Investigator: Alexandra Mangili, MD, MPH | |
| Principal Investigator: | Alexandra Mangili, MD, MPH | Tufts University School of Medicine |
More Information
Additional Information:
No publications provided
| Responsible Party: | Alexandra Mangili, MD, MPH, Tufts University School of Medicine |
| ClinicalTrials.gov Identifier: | NCT00846599 History of Changes |
| Other Study ID Numbers: | SUB730 |
| Study First Received: | February 17, 2009 |
| Last Updated: | December 2, 2009 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Tufts University:
|
brachial artery ultrasound brachial artery reactivity HIV human immunodeficiency virus cardiovascular risk omega three |
saturated fat sustiva atripla kaletra treatment naive |
Additional relevant MeSH terms:
|
HIV Infections Acquired Immunodeficiency Syndrome Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases |
Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases Slow Virus Diseases |
ClinicalTrials.gov processed this record on May 19, 2013